---
title: "Charles Mullighan"
permalink: /partners_investigators/
published: true
isPublic_b: true
order_ti: 9
########################################

type_txt: x01-investigator
name_txt: "Charles Mullighan"
almaMater_txt: "St. Jude Children's Research Hospital"
researchFocus_txt: ''
logoRef_txt:  __images/charles-mullighan.md
quote_txt: ''

---

Dr. Mullighan is a member of the Department of Pathology and Co-Leader of the Hematological Malignancies Program at St. Jude Childrenâ€™s Research Hospital. He received his training in medicine, hematology and hematopathology in Adelaide, Australia, and undertook doctoral studies in Immunogenetics at the University of Oxford. His research examines the genetic determinants of leukemogenesis and treatment response in acute lymphoblastic leukemia and related disorders. His work has identified multiple new subtypes of ALL, and has identified several genetic alterations that have entered the clinic as new diagnostic and therapeutic targets. His work has been published in over 200 peer-reviewed publications, including Nature, Nature Genetics, Science and the New England Journal of Medicine.

